The Role of Human Dendritic Cells in HIV-1 Infection

Slides:



Advertisements
Similar presentations
HIV and its lifecycle Sources: Wikipedia, HIV is a retrovirus (enveloped viruses possessing an RNA genome,
Advertisements

Reviewed by Christina Ziegler
19.09 Replication of HIV Slide number: 1
Virus Replication John Goulding, Imperial College London, UK
Antigen-Primed CD8+ T Cells Call DCs for Back Up
Mirjam B. Zeisel, Isabel Fofana, Samira Fafi-Kremer, Thomas F. Baumert 
Intrinsic Cellular Defenses against Human Immunodeficiency Viruses
Influenza A Virus Lures Autophagic Protein LC3 to Budding Sites
Engineering T Cells to Functionally Cure HIV-1 Infection
Björn E. Clausen, Stephan Grabbe  Journal of Investigative Dermatology 
The Influenza Virus Enigma
The Late Endosomal Adaptor Molecule p14 (LAMTOR2) Regulates TGFβ1-Mediated Homeostasis of Langerhans Cells  Florian Sparber, Christoph H. Tripp, Kerstin.
Volume 159, Issue 5, Pages (November 2014)
Tetherin: Holding On and Letting Go
Craig A. Elmets, Johnathan J. Ledet, Mohammad Athar 
Matthew O. Ivory, James C. Birchall, Vincent Piguet 
TGFβ Induces a SAMHD1-Independent Post-Entry Restriction to HIV-1 Infection of Human Epithelial Langerhans Cells  Magdalena A. Czubala, Katja Finsterbusch,
An Unexpected Role: UVA-Induced Release of Nitric Oxide from Skin May Have Unexpected Health Benefits  Gary M. Halliday, Scott N. Byrne  Journal of Investigative.
Clinical Snippets Journal of Investigative Dermatology
Damjan S. Nikolic, Vincent Piguet  Journal of Investigative Dermatology 
Kavitha K. Reddy  Journal of Investigative Dermatology 
Databases for Clinical Research
Oral Administration of the CCR5 Inhibitor, Maraviroc, Blocks HIV Ex Vivo Infection of Langerhans Cells within the Epithelium  Takamitsu Matsuzawa, Tatsuyoshi.
Down-RANKing the Threat of HSV-1: RANKL Upregulates MHC-Class-I-Restricted Anti- Viral Immunity in Herpes Simplex Virus Infection  Katja Finsterbusch,
Innate Immunity: Ignored for Decades, but Not Forgotten
Tyrosinase: A Central Regulatory Protein for Cutaneous Pigmentation
EFdA, a Reverse Transcriptase Inhibitor, Potently Blocks HIV-1 Ex Vivo Infection of Langerhans Cells within Epithelium  Takamitsu Matsuzawa, Tatsuyoshi.
Circulating Tumor Cells and Melanoma Progression
Manipulated Microenvironment in Human Papilloma Virus–Infected Epithelial Cells: Is the CD40–CD154 Pathway Beneficial for Host or Virus?  Takatoshi Shimauchi,
Nikhil Dhingra, Emma Guttman-Yassky 
Volume 134, Issue 4, Pages (August 2008)
Development of Effective Vaccines against Pandemic Influenza
Volume 90, Issue 5, Pages (September 1997)
Jean Cadet, Thierry Douki  Journal of Investigative Dermatology 
Innate Immune Sensing of HIV-1 by Dendritic Cells
Michael S. Diamond, Theodore C. Pierson  Cell 
HIV-1 Vif: Counteracting Innate Antiretroviral Defenses
Clinical Snippets Journal of Investigative Dermatology
Minutes of the Board of Directors Meeting
Analysis of HIV-1-X4 Fusion with Immature Dendritic Cells Identifies a Specific Restriction that Is Independent of CXCR4 Levels  Marjorie Pion, Jean-Francois.
Phenotypic Heterogeneity in Hidradenitis Suppurativa (Acne Inversa): Classification Is an Essential Step Toward Personalized Therapy  John R. Ingram,
Star Trek Publishing Journal of Investigative Dermatology
JID VisualDx Quiz: May 2014 Journal of Investigative Dermatology
Journal of Investigative Dermatology
Journal of Investigative Dermatology 
Cellular Networks Involved in the Influenza Virus Life Cycle
Society for Investigative Dermatology 2010 Meeting Minutes
Journal of Investigative Dermatology
Democratizing the Clinical Trials Agenda in Dermatology
BJD Editor's Choice Journal of Investigative Dermatology
Cells of Origin in Skin Cancer
IL-4 and IL-13 Alter Plasmacytoid Dendritic Cell Responsiveness to CpG DNA and Herpes Simplex Virus-1  Jurjen Tel, Ruurd Torensma, Carl G. Figdor, I.
Research Snippets Journal of Investigative Dermatology
Clinical Snippets Journal of Investigative Dermatology
Journal of Investigative Dermatology
How Much Sun Protection Is Needed
Greg J. Towers, Mahdad Noursadeghi  Cell Host & Microbe 
Volume 8, Issue 1, Pages (July 2010)
Research Snippets from the British Journal of Dermatology
TLR3: A Receptor that Recognizes Cell Injury Is Essential for Permeability Barrier Homeostasis Following UV Irradiation  Kenneth R. Feingold  Journal.
25 Years of Epidermal Stem Cell Research
Journal of Investigative Dermatology
John P. Sundberg, Lloyd E. King 
Journal of Investigative Dermatology
Consequences of Psychological Distress in Adolescents with Acne
Journal of Investigative Dermatology
Journal of Investigative Dermatology
Innate Immunity Stimulates Permeability Barrier Homeostasis
Hematopoietic-Stem-Cell-Based Gene Therapy for HIV Disease
HIV and Chemokine Binding to Red Blood Cells—DARC Matters
Presentation transcript:

The Role of Human Dendritic Cells in HIV-1 Infection Zahra Ahmed, Tatsuyoshi Kawamura, Shinji Shimada, Vincent Piguet  Journal of Investigative Dermatology  Volume 135, Issue 5, Pages 1225-1233 (May 2015) DOI: 10.1038/jid.2014.490 Copyright © 2015 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 1 Human dendritic cell (DC) subsets and the role in HIV infection. LCs, Langerhans cells; pDCs, plasmacytoid dendritic cells. Journal of Investigative Dermatology 2015 135, 1225-1233DOI: (10.1038/jid.2014.490) Copyright © 2015 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 2 Infection of dendritic cells (DCs) and restriction steps. HIV-1 binds to CD4 and chemokine receptor CCR5, allowing infection of DCs via fusion with cell membrane. However, there are several restriction factors preventing HIV-1 propagation acting at different stages of the viral life cycle shown in blue. Tripartite motif-5α (TRIM-5α) binds to the viral capsid to help disrupt its disassembly. The counteracting viral factor Gag capsid antigen (Gag-CA) is shown in red. Sterile alpha motif and HD domain 1 (SAMHD1) potently blocks reverse transcription at this post-entry step by reducing dNTPs pool, with the counteracting viral factor protein X (Vpx) shown in red. Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G) incorporates itself into newly made virions and restricts HIV replication potentially via limiting reverse transctiption and by causing hypermutation. The counteracting viral factor is virion infectivity factor (Vif), shown in red. Myxovirus resistance 2 (MX2) offers IFN-α-mediated resistance to multiple HIV strains by blocking the virus at a late post-entry stage, and finally tetherin prevents viral budding and release by tethering the virus at the cell surface. The counteracting viral factor Vpu is shown in red. Journal of Investigative Dermatology 2015 135, 1225-1233DOI: (10.1038/jid.2014.490) Copyright © 2015 The Society for Investigative Dermatology, Inc Terms and Conditions